Novaliq’s NovaTears®+Omega-3 Approved in Europe for the Enhanced Treatment of Evaporative Dry Eye Disease

HEIDELBERG, Germany--(BUSINESS WIRE)--#CyclASol--Novaliq announced the European registration of NovaTears®+Omega-3 for the enhanced treatment of the signs and symptoms of evaporative dry eye disease.

Full Story →